CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

Blue Cross NC

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
A
Index (ASP = 100)
105.7
Vs. acquisition
+2.9%
Brand index
105.6
Biosimilar index
121.8
Contract variability
Medium
Drugs observed
844
States
52

Contracts above the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 3 distinct contracted rates across practices, with 94% of billing volume on the single most common rate — a card system — a few standard rates, most practices on the standard one.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.